10,110 Shares in Stryker Corporation $SYK Bought by M Holdings Securities Inc.

M Holdings Securities Inc. acquired a new stake in Stryker Corporation (NYSE:SYK) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 10,110 shares of the medical technology company’s stock, valued at approximately $2,784,000.

Other hedge funds have also modified their holdings of the company. Community Bank & Trust Waco Texas boosted its stake in Stryker by 2.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock valued at $439,000 after buying an additional 31 shares in the last quarter. Cornerstone Financial Management LLC grew its position in Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after acquiring an additional 31 shares during the period. NWF Advisory Services Inc. raised its stake in Stryker by 2.3% during the second quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company’s stock worth $463,000 after acquiring an additional 33 shares in the last quarter. Private Harbour Investment Management & Counsel LLC raised its stake in Stryker by 0.9% during the second quarter. Private Harbour Investment Management & Counsel LLC now owns 3,927 shares of the medical technology company’s stock worth $1,236,000 after acquiring an additional 34 shares in the last quarter. Finally, Natural Investments LLC raised its stake in Stryker by 1.2% during the second quarter. Natural Investments LLC now owns 2,789 shares of the medical technology company’s stock worth $878,000 after acquiring an additional 34 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Stryker Stock Down 0.2%

Shares of SYK opened at $325.26 on Monday. The firm has a market capitalization of $123.83 billion, a price-to-earnings ratio of 34.64, a PEG ratio of 2.24 and a beta of 0.78. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. The business’s fifty day moving average price is $292.37 and its two-hundred day moving average price is $323.59. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). Stryker had a return on equity of 23.74% and a net margin of 13.78%. The firm had revenue of $6.52 billion for the quarter, compared to the consensus estimate of $6.62 billion. During the same quarter in the previous year, the firm earned $3.19 EPS. The company’s revenue was up 7.6% compared to the same quarter last year. On average, analysts predict that Stryker Corporation will post 14.84 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on SYK. TD Cowen cut their price objective on Stryker from $298.00 to $290.00 and set a “hold” rating for the company in a report on Friday, October 30th. UBS Group lowered their target price on shares of Stryker from $400.00 to $382.00 and set a “buy” rating on the stock in a report on Monday, August 3rd. Citigroup reiterated a “market outperform” rating on shares of Stryker in a research report on Friday, October 30th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Stryker from $315.00 to $275.00 and set a “hold” rating for the company in a research report on Friday, October 30th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a report on Thursday, October 29th. Twenty-one equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $343.73.

Insider Buying and Selling

In other Stryker news, insider Debra King sold 826 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. The trade was a 11.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronda Stryker sold 50,000 shares of the business’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total value of $17,005,000.00. Following the sale, the director directly owned 2,251,375 shares of the company’s stock, valued at $765,692,637.50. This represents a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 over the last three months. 4.60% of the stock is currently owned by company insiders.

Stryker Profile

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr.